CLDN4 and gastric cancer: Several reports have indicated that claudin-4 binders are effective in treating cancer (e.g., pancreatic, ovarian, breast, colorectal and gastric cancer cells)23,24,45–47 and can be delivered as a vaccine to mucosal immune tissue44,48,49.